This message contains images. If you don't see images, click here to view.
Advertise in this news brief.



Text version   RSS   Subscribe   Unsubscribe   Archive   Media Kit August 20, 2015
Advertisement
   NAMCP Medical Directors Institute   AAMCN    AAIHDS    Conferences    JMCM    Contact Us  








Check out JMCM’s new website at www.jmcmpub.org

Seattle Genetics Announces FDA Regular Approval of ADCETRIS® for Classical Hodgkin Lymphoma Patients at High Risk of Relapse or Progression. Click here to view more information.

We wanted you to be aware that the FDA has granted accelerated approval of IBRANCE® (palbociclib) for the treatment of postmenopausal women with ER+/HER2- advanced breast cancer. Click here to see the press release!

Otezla® (apremilast) is approved for the treatment of patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. Please click here for more information.

OAs part of APhA's longstanding and ongoing commitment to helping its members ensure optimal and safe patient use of prescription medications, nonprescription products, and dietary supplements, APhA convened national pharmacy and medicine leaders and other stakeholders on March 26. Click here for more information .

 



Fall Managed Care Forum: Register today!
NAMCP

Register today for the 2015 Fall Forum being held November 12-13, 2015 at The Bellagio in Las Vegas. Click here to visit the conference website.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  




GENOMICS


'Jumping genes' unusually active in many gastrointestinal cancers
Medical Xpress
Results of a trio of studies done on human cancer tissue biopsies have added to growing evidence that a so-called jumping gene called LINE-1 is active during the development of many gastrointestinal cancers. The Johns Hopkins scientists who conducted the studies caution there is no proof that the numerous new "insertions" of these rogue genetic elements in the human genome actually cause cancers, but they say their experiments do suggest that these elements, formally known as transposons, might one day serve as a marker for early cancer diagnosis.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Want to share your expertise?
MultiBriefs
In an effort to enhance the overall content of GBEMTI eNews, we'd like to include peer-written articles in future editions. As a member of NAMCP, your knowledge of the industry lends itself to unprecedented expertise. And we're hoping you'll share this experience with your peers through well-written commentary. Make 2015 the year you get published as an expert in your field! Our group of talented editors can help with final edits. If you're interested in participating, please contact Ronnie Richard to discuss logistics.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


SPONSORED CONTENT


Testing for more breast cancer genes offers useful information
Reuters via Fox News
When the results of a test wouldn’t change how doctors manage a patient’s care, most say it’s not worth doing. But new tests for breast cancer risk mutations beyond the well-known BRCA genes would offer actionable information for many women and their doctors, a new study finds.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Do the genes of warriors win the evolution battle?
The Wall Street Journal
“War — what is it good for? Absolutely nothing. Say it again.” So runs the 1970 pop song that Edwin Starr made famous and that’s now the obligatory soundtrack for every documentary about the Vietnam antiwar movement. For the historians, anthropologists and economists who study warfare, it’s more complicated than that. The sheer ubiquity of war across time and place suggest that it must be good for something.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Outcome-based Approaches For Reimbursement

Through the application of state-of-the-art genomic technologies, CGI provides clinical knowledge that we believe will allow both clinicians and healthcare providers to tailor treatments to individuals.

CGI is committed to enhancing the lives of oncology patients, increasing quality of care, and lowering overall healthcare costs through innovation in cancer diagnostics. Learn more
 


BIOTECH/DIAGNOSTICS/PERSONALIZED MEDICINE


Can Medicare afford personalized medicine?
The San Diego Union-Tribune
Personalized medicine is the future of healthcare, but it is not yet clear exactly what that means for Medicare. As it reaches its 50th anniversar, the nation’s largest health program is at a critical moment. The program, which is projected to spend more than $600 billion this year, must find ways to slow its spending as personalized medicine creates an ever-greater demand for expensive new medicines and tests with price tags closer to Ferrari than Ford.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


REGENERATIVE MEDICINE


Rush researchers explore new stem cell therapy to treat spinal cord injuries
News-Medical.net
Researchers at Rush University Medical Center are exploring a new therapy using stem cells to treat spinal cord injuries within the first 14 to 30 days of injury. Rush is only the second center in the country currently studying this new approach. The therapy uses a population of cells derived from human embryonic stem cells containing progenitor cells that support nerve cells and can potentially make poorly functioning nerves function better.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


SPONSORED CONTENT


Can stem cells cause and cure cancer?
Medical Xpress
Simply put, cancer is caused by mutations to genes within a cell that lead to abnormal cell growth. Finding out what causes that genetic mutation has been the holy grail of medical science for decades. Researchers at the Texas A&M Health Science Center Institute of Biosciences and Technology believe they may have found one of the reasons why these genes mutate and it all has to do with how stem cells talk to each other.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


EMERGING MEDICAL TECHNOLOGIES


Report: Top technology trends across the realm of healthcare
By Scott E. Rupp
In its summer 2015 Health Tech Report, CDW profiles the 10 most current and pressing trends of which those in healthcare should take notice. The list is expansive and somewhat obvious in areas, but provides insight into the changing landscape of the current healthcare technology sector — which is no stranger to constant movement. It's worth noting such trends provide the foundation of where the industry is headed in regard to raising quality, security and satisfaction.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Getting Patients Back to Better

Vibra hospitals provide specialized care in the right setting at the right time. Whether your patient’s needs are medically complex or rehabilitative, you can count on seamless transitions and ongoing communications with you and your care team. Our specialists are your partners in getting patients back to better.
 


Now Yelp can help patients pick a hospital or doctor
By Joan Spitrey
When people consider the online review service Yelp, most think about local businesses like restaurants, hair stylists or mechanics. Doctors and hospitals? Not so much. Yelp has allowed and encouraged its "Yelpers" to review and rate healthcare organizations. Up to this point, though, the reviews have all been consumer opinions and experiences. However, Yelp recently announced a new feature that would include actual data for hospitals, nursing homes and dialysis clinics.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


  FEATURED COMPANIES
SOAPware. Exceptional Software. Empowering Healthcare.
Ranked #1 in the Nation for Quality of Care. Our Meaningful Use certified software is designed by medical providers, making SOAPware the preferred EHR for medical professionals! MORE
Advertise here!

To find out how to feature your company in the GBEMTI eNewsletter and other advertising opportunities, Contact Geoffrey Forneret at 469-420-2629.
MORE


ACCOUNTABLE CARE ORGANIZATIONS


Accountable care, big data analytics attract vendor attention
Health IT Analytics
Product vendors and service providers targeting the healthcare systems’ growing appetite for advanced big data analytics and accountable care capabilities are continuing to make strategic moves in a swiftly changing marketplace. With billions of dollars of revenue potentially up for grabs as providers seek to position themselves for success in a value-based reimbursement universe, visionaries, venture capitalists, and savvy executives are gobbling up smaller rivals and funding innovative ideas in a volatile health IT environment.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Emerging ACO best practices for shared savings
Health Data Management
Only about one-quarter of participants in Medicare’s shared savings accountable care program actually generated shared savings, as did only 12 of 32 original Medicare Pioneer ACO participants; 13 of the original 32 have dropped out. Despite mixed results, there were impressive performances among the successful pioneer organizations.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FDA: NEW TREATMENTS AND TECHNOLOGY


Low libido? FDA weighs drug to drive women's desire
USA Today
The drug makers of a "little pink pill" touted as a boost for female sexual desire will learn its fate when the Food and Drug Administration decides whether to approve the drug as a treatment for low libido in women. Depending on your point of view, the pill, flibanserin — popularly, but incorrectly, dubbed the "female Viagra" — is either the answer to a woman's prayers or a risky drug that turns a normal condition into a medical problem that only pharmaceuticals can solve.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FDA says endoscope makers failed to report superbug problems
NBC News
Federal regulators have uncovered new violations by the manufacturer of medical scopes recently linked to outbreaks of deadly "superbug" bacteria at U.S. hospitals. Olympus Corp. failed to alert regulators to a cluster of 16 infections in patients who underwent procedures with the company's scope in 2012, according to a warning letter posted by the Food and Drug Administration.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


MANAGED HEALTHCARE NEWS


Most health insurance co-ops are losing money, federal audit finds
The New York Times
Most federal insurance cooperatives created under the Affordable Care Act are losing money and could have difficulty repaying millions of dollars in federal loans, an internal government audit has found, prompting the Obama administration to step up supervision of the carriers. Daniel R. Levinson, the inspector general at the Department of Health and Human Services, said that most of the insurance co-ops enrolled fewer people than they had predicted, and that 22 of the 23 co-ops lost money last year.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


A change to out-of-pocket health insurance limits irks employers
NPR
One of the health law's key protections was putting a cap on how much people can be required to pay out of pocket for medical care each year. Now some employers say the administration is unfairly changing the rules that determine how those limits are applied and that the changes will be costly.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    Can genes make us liberal or conservative? (Discovery News)
Scientists pinpoint how a single genetic mutation causes autism (Medical Xpress)
Bill Gates and 13 other investors pour $120M into revolutionary gene-editing startup (Forbes)
Healthcare will be Uber-ized (CNN)
Doctors call new FDA-approved cellulite treatment revolutionary (KPRC-TV)

Don't be left behind. Click here to see what else you missed.
 

Genomics Biotech and Emerging Medical Technologies Institute eBrief
Colby Horton, Vice President of Publishing, 469.420.2635
Download media kit

Natalie Rodriguez, Senior Content Editor, 469.420.2635   
Contribute news

This edition of the Genomics Biotech and Emerging Medical Technologies Institute eBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
Aug. 13, 2015
August 6, 2015
July 30, 2015
July 23, 2015



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063